After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. The stock was recently discussed on Yahoo Finance as it revealed that MindMed to Host Conference Call and Webcast to Discuss Data Update for MM120.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $5.94 and fluctuated between $6.37 as its day high and $5.79 as its day low. The current market capitalization of Mind Medicine Inc is $167.27M. A total of 0.94 million shares were traded on the day, compared to an average of 778.01K shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, MNMD has seen 0 BUY and 3 SELL insider trades, representing the acquisition of 0 and the disposition of 25,663 shares. Over the last 12 months, there were 17 BUYs and 23 SELLs from insiders. Insiders purchased 1,501,202 shares during that period but sold 548,616.
In the most recent transaction, Barrow Robert sold 13,237 shares of MNMD for 3.63 per share on Dec 26. After the transaction, the Chief Executive Officer now owns 596,721 company shares. In a previous transaction on Dec 26, Karlin Dan sold 6,774 shares at 3.63 per share. MNMD shares that Chief Medical Officer owns now total 365,030.
Among the insiders who sold shares, Greenway Schond L. disposed of 5,652 shares on Dec 26 at a per-share price of $3.63. This resulted in the Chief Financial Officer holding 216,617 shares of MNMD after the transaction. In another insider transaction, Barrow Robert sold 13,499 shares at $3.58 per share on Sep 25. Company shares held by the Chief Executive Officer now total 611,729.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, MNMD has a high of $6.47 and a low of $2.41.
As of this writing, MNMD has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 6 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.56. The company reported an EPS of -$0.45 in the last quarter, which was 32.80% higher than expectations of -$0.67.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MNMD’s latest balance sheet shows that the firm has $133.54M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.41M in liabilities at the time. Its Book Value Per Share was $1.90, while its Total Shareholder’s Equity was $151.66M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNMD is Buy with a score of 4.86.
